Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition
Biwei Pei, Na Zhang, Tingting Pang, Gengyun Sun
Topics & Concepts
LinagliptinFibrosisPulmonary fibrosisMedicineIn vivoDipeptidyl peptidase-4Mesenchymal stem cellInflammationOxidative stressPharmacologyCancer researchImmunologyPathologyBiologyDiabetes mellitusInternal medicineEndocrinologyType 2 diabetesBiotechnologyInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisSystemic Sclerosis and Related DiseasesPulmonary Hypertension Research and Treatments